Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: back pain

What Role Does Fascia Play in Rheumatic Diseases?

Helene M. Langevin, MD  |  March 1, 2014

Recent research explores possible connections between abnormalities in fasciae and painful musculoskeletal conditions such as chronic back pain, osteoarthritis, and rheumatoid arthritis, as well as scleroderma

Filed under:ConditionsOsteoarthritis and Bone DisordersPain SyndromesResearch RheumRheumatoid ArthritisSystemic Sclerosis Tagged with:anti-inflammatoryFibromyalgiaOsteoarthritisPainpatient careResearchRheumatic DiseaseRheumatoid arthritisrheumatologistScleroderma

John F. Kennedy’s Odyssey in Search of Diagnosis

Simon M. Helfgott, MD  |  November 1, 2013

Myriad health conditions from back pain to gastrointestinal illness plagued the late president and baffled his physicians

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:DiagnosisRheumatic Disease

ACR Increases Its Role in Educating Rheumatologists About Treating Geriatric Patients

Vanessa Caceres  |  November 1, 2012

Sessions on aging and rheumatic disease, arthritis and the older worker, and back pain in the elderly included at the annual meeting of the American College of Rheumatology and Association of Rheumatology Healthcare Professionals (ACR/ARHP)

Filed under:Career DevelopmentEducation & TrainingLegislation & AdvocacyMeeting ReportsPractice SupportProfessional TopicsQuality Assurance/ImprovementResearch Rheum Tagged with:AC&RACR/ARHP Annual MeetingAdvocacyAmerican College of Rheumatology (ACR)EducationgeriatricPatientsPractice ManagementResearchRheumatology Research FoundationTraining

Rich Data: ARP Abstracts at ACR Convergence 2025

Louise M. Thoma, PT, DPT, PhD  |  April 7, 2025

This year, rheumatology professionals in the U.S. and across the world will descend on the Windy City (Chicago) for ACR Convergence 2025. This meeting is the premier gathering place for up-to-date rheumatology education. Although the education sessions provide rich syntheses of evidence you can apply to your next patient, the real treasure is in the…

Filed under:ACR ConvergenceInterprofessional Perspective Tagged with:abstract submissionACR Convergence 2025Association of Rheumatology Professionals (ARP)

Reproductive Health, Biosimilars & More in Focus at SOTA 2025

Ruth Jessen Hickman, MD  |  January 30, 2025

Reproductive health, biosimilars, IgG4-related disease and much more—five speakers give us a sneak peek into important topics being addressed at the ACR’s 2025 State-of-the-Art Clinical Symposium, April 4–6.

Filed under:Biologics/DMARDsConditionsEducation & TrainingGuidanceMeeting ReportsOther ACR meetings Tagged with:ACR State-of-the-Art Clinical SymposiumBiosimilarsIgG4 related diseaseLupusOsteoporosispregnancypregnancy complicationspregnant womenskinState-of-the-Art Clinical Symposium

Adobe Stock | Creativa Images

RA: How High Is the Toll?

Samantha C. Shapiro, MD  |  January 9, 2025

Patients with RA not only suffer from functional limitations, but also face increased healthcare costs, primarily due to prescription drug use, says Dr. Yinan Huang.

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:economic burdenMSPhDphysical burdenRA Resource CenterYinan Huang

Key Research in Axial Spondyloarthritis Encapsulated

David S. Pisetsky, MD, PhD  |  December 2, 2024

Our understanding of (axSpA) has really changed, especially with regard to male-female differences. In this report, we identify important research on axSpA presented at ACR Convergence 2024, summarize the abstracts and comment on why each is important, addressing the relevance for clinicians and the potential impact on future research.

Filed under:ACR ConvergenceAxial SpondyloarthritisConditionsGuidanceMeeting Reports Tagged with:ACR Convergence 2024ACR Convergence 2024 axSpA

As ARP President, Adam Goode, PT, DPT, PhD, Will Draw on Power of Interdisciplinary Members

Leslie Mertz, PhD  |  November 23, 2024

The diversity of the ARP’s membership is what originally drew Adam Goode, PT, DPT, PhD, to the organization, enticed him to begin volunteering more than a decade ago and now galvanizes him as he becomes the new ARP president.

Filed under:From the CollegeInterprofessional PerspectiveProfiles Tagged with:ARP presidentLeadership

The Management of Psoriatic Arthritis: A Review

Samantha C. Shapiro, MD  |  November 17, 2024

WASHINGTON, D.C.—As of November 2024, there are 16 biologic disease-modifying anti-rheumatic drugs (bDMARDs) that are FDA approved for the treatment of psoriatic arthritis (PsA). Incredible news, right? But as my fellowship program director used to say, “There’s no free lunch.” This buffet of options is excellent for our patients, but poses challenges to the practicing…

Filed under:ACR ConvergenceConditionsGuidanceMeeting ReportsPsoriatic Arthritis Tagged with:ACR Convergence 2024ACR Convergence 2024 PsA

Meet the Professor: Axial Spondyloarthritis

Keri Losavio  |  October 14, 2024

Axial spondyloarthritis (axSpA) is a complex, immune-mediated inflammatory disorder characterized by inflammatory back pain and axial arthritis. Typical of other diseases in the spondyloarthritis family, the clinical phenotypes can be diverse, and an array of comorbidities often accompanies the spinal disease. “In this Meet the Professor Session at ACR Convergence 2024,” says Christopher Ritchlin, MD,…

Filed under:ACR ConvergenceAxial SpondyloarthritisConditions Tagged with:ACR Convergence 2024ACR Convergence 2024 axSpA

  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 162
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences